Leveraging The Power Of Advanced Mass Spectrometry To Fulfill IND, IMPD And BLA Filings

By Greg Adams, Senior Director, Global Analytical Strategy & Development

Mass Spectrometry (MS) is one of the most powerful analytical techniques available for protein characterization. MS can provide data on the quantity, structural integrity, and post-translational modifications of proteins. MS techniques have broad applicability for characterizing biopharmaceuticals, such as identifying post-translation modifications and structural characterization of biopharmaceutical proteins, product identification, comparability, biosimilarity, and quantifying host-cell protein impurities.

At FUJIFILM Diosynth Biotechnologies (FDB), we partner with our clients to help ensure they have the right product characterization data they need for timely regulatory filings. In this article, learn more about technological advances in MS instrumentation and the experience and capabilities that FDB provides.